Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Teva boss hits out at opioid lawsuits | Financial Times
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Report: Teva Settles Investor Lawsuit for $420M - Hamodia.com
Teva, Israel's Biggest Country, In Opioid Legal Trouble – The Forward
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva suffers trial loss in New York's landmark opioid case | FiercePharma
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Opioid Lawsuit Against Teva Pharma
J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | FiercePharma
Teva Stock: Wait And See On This Stock (NYSE:TEVA) | Seeking Alpha
Teva wins opioids case in California court - Globes
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva's generic label not skinny enough to protect from $234M damages to GSK - MedCity News
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
Teva shares tumble as company faces price-fixing lawsuit - The Jerusalem Post
Teva Loses New York Lawsuit over Painkillers – Stock Plummets - Jewish Business News
